{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:48:03Z","timestamp":1762505283291},"reference-count":29,"publisher":"Portland Press Ltd.","issue":"1","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,11,15]]},"abstract":"<jats:p>Destabilization of the tetrameric fold of TTR (transthyretin) is important for aggregation of the protein which culminates in amyloid fibril formation. Many TTR mutations interfere with tetramer stability, increasing the amyloidogenic potential of the protein. The vast majority of proposed TTR fibrillogenesis inhibitors are based on in vitro assays with isolated protein, limiting their future use in clinical assays. In the present study we investigated TTR fibrillogenesis inhibitors using a cellular system that produces TTR intermediates\/aggregates in the medium. Plasmids carrying wild-type TTR, V30M or L55P cDNA were transfected into a rat Schwannoma cell line and TTR aggregates were investigated in the medium using a dot-blot filter assay followed by immunodetection. Results showed that, in 24\u00a0h, TTR L55P forms aggregates in the medium, whereas, up to 72\u00a0h, wild-type TTR and V30M do not. A series of 12 different compounds, described in the literature as in vitro TTR fibrillogenesis inhibitors, were tested for their ability to inhibit L55P aggregate formation; in this system, 2-[(3,5-dichlorophenyl) amino] benzoic acid, benzoxazole, 4-(3,5-difluorophenyl) benzoic acid and tri-iodophenol were the most effective inhibitors, as compared with the reference iododiflunisal, previously shown by ex vivo and in vitro procedures to stabilize TTR and inhibit fibrillogenesis. Among these drugs, 2-[(3,5-dichlorophenyl) amino] benzoic acid and tri-iodophenol stabilized TTR from heterozygotic carriers of V30M in the same ex vivo conditions as those used previously for iododiflunisal. The novel cellular-based test herein proposed for TTR fibrillogenesis inhibitor screens avoids not only lengthy and cumbersome large-scale protein isolation steps but also artefacts associated with most current in vitro first-line screening methods, such as those associated with acidic conditions and the absence of serum proteins.<\/jats:p>","DOI":"10.1042\/bj20070689","type":"journal-article","created":{"date-parts":[[2007,10,29]],"date-time":"2007-10-29T14:59:59Z","timestamp":1193669999000},"page":"131-138","update-policy":"http:\/\/dx.doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Comparative <i>in vitro<\/i> and <i>ex vivo<\/i> activities of selected inhibitors of transthyretin aggregation: relevance in drug design"],"prefix":"10.1042","volume":"408","author":[{"given":"Isabel","family":"Cardoso","sequence":"first","affiliation":[{"name":"Molecular Neurobiology Unit, IBMC, University of Porto, 4150-180 Porto, Portugal"}]},{"given":"Maria\u00a0Ros\u00e1rio","family":"Almeida","sequence":"additional","affiliation":[{"name":"Molecular Neurobiology Unit, IBMC, University of Porto, 4150-180 Porto, Portugal"},{"name":"ICBAS, University of Porto, Porto, Portugal"}]},{"given":"Nelson","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Molecular Neurobiology Unit, IBMC, University of Porto, 4150-180 Porto, Portugal"},{"name":"ICBAS, University of Porto, Porto, Portugal"}]},{"given":"Gemma","family":"Arsequell","sequence":"additional","affiliation":[{"name":"Instituto de Investigaciones Qu\u00edmicas y Ambientales de Barcelona, Consejo Superior de Investigaciones Cient\u00edficas (IIQAB-CSIC), 08034 Barcelona, Spain"}]},{"given":"Gregorio","family":"Valencia","sequence":"additional","affiliation":[{"name":"Instituto de Investigaciones Qu\u00edmicas y Ambientales de Barcelona, Consejo Superior de Investigaciones Cient\u00edficas (IIQAB-CSIC), 08034 Barcelona, Spain"}]},{"given":"Maria\u00a0Jo\u00e3o","family":"Saraiva","sequence":"additional","affiliation":[{"name":"Molecular Neurobiology Unit, IBMC, University of Porto, 4150-180 Porto, Portugal"},{"name":"ICBAS, University of Porto, Porto, Portugal"}]}],"member":"288","published-online":{"date-parts":[[2007,10,29]]},"reference":[{"key":"2021112213355127500_B1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1385\/JMN:23:1-2:035","article-title":"Familial amyloidotic polyneuropathy: protein aggregation in the peripheral nervous system","volume":"23","author":"Saraiva","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"2021112213355127500_B2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/74082","article-title":"Rational design of potent human transthyretin amyloid disease inhibitors","volume":"7","author":"Klabunde","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"2021112213355127500_B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-894X(98)00696-9","article-title":"Synthesis and evaluation of anthranilic acid-based transthyretin amyloid fibril inhibitors","volume":"9","author":"Oza","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2021112213355127500_B4","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0968-0896(98)00130-8","article-title":"Discovering transthyretin amyloid fibril inhibitors by limited screening","volume":"6","author":"Baures","year":"1998","journal-title":"Bioorg. Med. Chem."},{"key":"2021112213355127500_B5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0968-0896(99)00066-8","article-title":"Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid","volume":"7","author":"Baures","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"2021112213355127500_B6","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1002\/anie.200351179","article-title":"Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action","volume":"42","author":"Razavi","year":"2003","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2021112213355127500_B7","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0002-9440(10)64469-0","article-title":"Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin","volume":"161","author":"Sousa","year":"2002","journal-title":"Am. J. Pathol."},{"key":"2021112213355127500_B8","article-title":"Molecular Cloning: a Laboratory Manual","author":"Sambrook","year":"1989","edition":"2nd edition"},{"key":"2021112213355127500_B9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0022-2275(20)32074-5","article-title":"Transthyretin in high density lipoproteins: association with apolipoprotein A-I","volume":"41","author":"Sousa","year":"2000","journal-title":"J. Lipid Res."},{"key":"2021112213355127500_B10","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1073\/pnas.90.11.5011","article-title":"Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases","volume":"90","author":"Henzel","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112213355127500_B11","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1021\/bi00223a017","article-title":"Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP)","volume":"30","author":"Furuya","year":"1991","journal-title":"Biochemistry"},{"key":"2021112213355127500_B12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF02820508","article-title":"Thyroxine binding to transthyretin Met119. Comparative studies of different heterozygotic carriers and structural analysis","volume":"6","author":"Almeida","year":"1997","journal-title":"Endocrine"},{"key":"2021112213355127500_B13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"2021112213355127500_B14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/elps.1150020305","article-title":"Demonstration of human prealbumin by double one-dimensional slab gel electrophoresis","volume":"2","author":"Altland","year":"1981","journal-title":"Electrophoresis"},{"key":"2021112213355127500_B15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/BJ20040011","article-title":"Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative","volume":"381","author":"Almeida","year":"2004","journal-title":"Biochem. J."},{"key":"2021112213355127500_B16","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0002-9440(10)63050-7","article-title":"Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates","volume":"159","author":"Sousa","year":"2001","journal-title":"Am. J. Pathol."},{"key":"2021112213355127500_B17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1699-0463.1997.tb05059.x","article-title":"An in vitro cellular system for generation of AA amyloid","volume":"105","author":"Palm","year":"1997","journal-title":"APMIS"},{"key":"2021112213355127500_B18","doi-asserted-by":"crossref","first-page":"11006","DOI":"10.1074\/jbc.272.17.11006","article-title":"Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells","volume":"272","author":"Kim","year":"1997","journal-title":"J. Biol. Chem."},{"key":"2021112213355127500_B19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00702-005-0318-0","article-title":"Overexpression of amyloid precursor protein induces susceptibility to oxidative stress in human neuroblastoma SH-SY5Y cells","volume":"113","author":"Matsumoto","year":"2006","journal-title":"J. Neural Transm."},{"key":"2021112213355127500_B20","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1124\/jpet.105.099317","article-title":"The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-\u03b2 peptide-induced neurotoxicity","volume":"317","author":"Iuvone","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2021112213355127500_B21","doi-asserted-by":"crossref","first-page":"14786","DOI":"10.1074\/jbc.270.24.14786","article-title":"Intracellular A\u03b21\u201342 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells","volume":"270","author":"Yang","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2021112213355127500_B22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/j.1460-2075.1993.tb05707.x","article-title":"Structure of Met30 variant of transthyretin and its amyloidogenic implications","volume":"12","author":"Terry","year":"1993","journal-title":"EMBO J."},{"key":"2021112213355127500_B23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/jm030347n","article-title":"Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis","volume":"47","author":"Adamski-Werner","year":"2004","journal-title":"J. Med. Chem."},{"key":"2021112213355127500_B24","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1021\/ja030294z","article-title":"Synthesis and characterization of potent bivalent inhibitors that bind prior to transthyretin tetramerization","volume":"125","author":"Greeen","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"2021112213355127500_B25","doi-asserted-by":"crossref","first-page":"15051","DOI":"10.1073\/pnas.93.26.15051","article-title":"Inhibiting transthyretin amyloid fibril formation via protein stabilization","volume":"93","author":"Miroy","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112213355127500_B26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1021\/jm010257n","article-title":"Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors","volume":"45","author":"Oza","year":"2002","journal-title":"J. Med. Chem."},{"key":"2021112213355127500_B27","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1096\/fj.02-0764com","article-title":"4\u2032-Iodo-4\u2032-deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing non-cytotoxic species. Screening for TTR fibril disrupters","volume":"17","author":"Cardoso","year":"2003","journal-title":"FASEB J."},{"key":"2021112213355127500_B28","doi-asserted-by":"crossref","first-page":"53483","DOI":"10.1074\/jbc.M408053200","article-title":"The crystal structure of transthyretin in complex with diethylstilbestrol: a promising template for the design of amyloid inhibitors","volume":"279","author":"Morais-de-Sa","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021112213355127500_B29","doi-asserted-by":"crossref","first-page":"14545","DOI":"10.1073\/pnas.0501609102","article-title":"Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis","volume":"102","author":"Green","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/408\/1\/131\/650689\/bj4080131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/408\/1\/131\/650689\/bj4080131.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T14:40:32Z","timestamp":1637592032000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/408\/1\/131\/42299\/Comparative-in-vitro-and-ex-vivo-activities-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,29]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,11,15]]}},"URL":"https:\/\/doi.org\/10.1042\/bj20070689","relation":{},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"value":"0264-6021","type":"print"},{"value":"1470-8728","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,29]]}}}